We are live on ! Find out more
IC

IEQ Capital Portfolio holdings

AUM $21.5B
1-Year Est. Return 75.26%
This Fund
S&P 500
This Quarter Est. Return
+13.16%
1 Year Est. Return
+75.26%
3 Year Est. Return
+200.43%
5 Year Est. Return
+196.91%
10 Year Est. Return
AUM
$4.96B
AUM Growth
+$644M
Cap. Flow
+$171M
Cap. Flow %
3.45%
Top 10 Hldgs %
37.64%
Holding
981
New
89
Increased
388
Reduced
336
Closed
81

Top Buys

Rank Stock Value
1
UPBD icon
Upbound Group
UPBD
+$47.1M
2
NBIX icon
Neurocrine Biosciences
NBIX
+$47M
3
RBLX icon
Roblox
RBLX
+$27.7M
4
JOBY icon
Joby Aviation
JOBY
+$15.4M
5
AAPL icon
Apple
AAPL
+$12.3M

Top Sells

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$12.8M
2
CRWD icon
CrowdStrike
CRWD
+$9.9M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$7.59M
4
SLAB icon
Silicon Laboratories
SLAB
+$7.54M
5
PEN icon
Penumbra
PEN
+$7.08M

Sector Composition

Rank Sector Weight
1 Technology 29.36%
2 Communication Services 13.07%
3 Consumer Discretionary 6.86%
4 Healthcare 6.72%
5 Financials 6.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOMA
976
DELISTED
Doma Holdings, Inc.
DOMA
-8,443
Closed -$86K
RXDX
977
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
-10,000
Closed -$1.07M
ABB
978
DELISTED
ABB Ltd
ABB
-8,091
Closed -$278K
SUMO
979
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
-235,154
Closed -$2.82M
FRC
980
DELISTED
First Republic Bank
FRC
-52,193
Closed -$730K

Similar funds

IEQ Capital's Q2 2023 Portfolio in Review

As of Q2 2023, IEQ Capital held 981 positions worth $4.96B, up 15% from $4.31B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

IEQ Capital deployed $171M of net new capital in Q2 2023, opening 89 new positions and adding to 388 existing holdings. Its largest new stake was Neurocrine Biosciences: 481,268 shares worth $45.4M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was Salesforce, an estimated $12.8M trimmed.

  • IEQ Capital's largest Q2 2023 buy was Neurocrine Biosciences: 481,268 shares worth $45.4M.
  • IEQ Capital added most to Upbound Group in Q2 2023, an estimated $47.1M increase.
  • IEQ Capital's biggest Q2 2023 reduction was Salesforce, cutting an estimated $12.8M.
  • IEQ Capital fully exited Penumbra in Q2 2023, selling an estimated $7.08M.
  • IEQ Capital's ten largest holdings make up 38% of its $4.96B portfolio in Q2 2023.
  • IEQ Capital opened 89 new positions and closed 81 in Q2 2023.
  • IEQ Capital's portfolio value rose 15% quarter-over-quarter to $4.96B.

Based on IEQ Capital's 13F filing for Q2 2023, filed 8 Aug 2023.